Fibromyalgia and Sleep Disorder Treatment
Launched by UPPSALA UNIVERSITY · Jan 15, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The main aim of this study is to evaluate the interaction between pain and sleep, both directly by comparing outcome measures of pain and sleep, and out of one inflammatory perspective using proteomics analyzes. Currently, there is a need for studies that highlight both the above-mentioned interaction and how the inflammatory response in the central nervous system as well as in the systemic circulation is involved. The cohort in existing study (FINE study) is already being used to find associations between these, but as it is a cross-sectional study, the design cannot determinate the causal...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Fibromyalgia according to 1990 and 2016 ACR (American College of Rheumatology criteria)
- • Included in FINE study
- • Sleep disorder
- Exclusion Criteria:
- • Other autoimmune or neuroinflammatory diseases than FM.
- • Other dominating pain conditions other than FM (e.g., severe pain due to osteoarthritis, disc herniations etc).
- • Severe somatic or psychiatric diseases that would preclude participation or influence results (e.g., cancer, infectious diseases etc).
- • Pregnancy.
- • Inability to speak and understand Swedish.
- • Treatment with anticoagulants.
- • High intracranial pressure.
- • Ongoing infections.
- • Hemophilia.
About Uppsala University
Uppsala University, a prestigious institution located in Sweden, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive expertise in various fields of health sciences to conduct innovative studies aimed at improving patient outcomes and understanding complex diseases. With a strong emphasis on ethical standards and rigorous scientific methodologies, Uppsala University collaborates with a network of researchers, healthcare professionals, and industry partners to facilitate groundbreaking clinical trials that contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Uppsala, , Sweden
Patients applied
Trial Officials
Romana Stehlik, PhD
Principal Investigator
Pain center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported